This newsletter is packed with opportunities to connect, learn, and contribute. Whether you’re interested in cutting-edge research, community engagement, or powerful advocacy, there’s something here for everyone. Let’s explore what’s happening in the KidneyCAN community this month!

Get ready for the Kidney Cancer Research Summit (KCRS24)!

KCRS is a meeting of clinicians, researchers, research advocates, scientists, medical oncologists, patients, industry, and others to discuss the future efforts for collaboration in the field of kidney cancer research.

We're excited to offer FREE virtual registration to patients and caregivers, as well as medical and research professionals, ensuring access to valuable discussions on the latest research advancements and treatment strategies.

Check out the full agenda and secure your spot for this enriching experience that brings the kidney cancer community together.

Let's lace up our shoes and get moving to accelerate cures for kidney cancer!

Join us for Rock the Run 2024, where your steps can lead to leaps in research funding! Slated for July, we've set an ambitious goal of raising $50,000 to go directly to funding kidney cancer research.

Whether you join us physically in Boston for the 5k at KCRS or participate virtually from your hometown, your involvement will drive crucial research funding forward. You can create or join a team, engage in a local run, walk, bike, or hike, and be a part of our nationwide effort to support kidney cancer research.

Start a team, find or create an event, and let's go!

ICYMI: Real talk on clinical trials , with insights from doctors and patients. Resources and video from our latest Town Hall are now available!

KidneyCAN 's April Town Hall featured candid and enlightening conversations about clinical trials for kidney cancer.

Our most recent Town Hall was a phenomenal success, drawing attendees from across the globe who are navigating kidney cancer.

Missed out? No problem. We’ve uploaded the entire session, complete with all the engaging discussions and invaluable resources discussed. Catch up on everything you missed and continue to access support at our website:

Leah Christoforidis (second from left) is a wife and mother of four, a patient with stage IV kidney cancer, and a fierce advocate for research funding. We are delighted to share her story in this month's KidneyCAN Community Spotlight.

This month, we spotlight Leah Christoforidis, an extraordinary advocate and mother of four battling kidney cancer. Diagnosed with a rare kidney cancer at 32 weeks of pregnancy, Leah's had to learn quite a bit about advocating for herself.

She has turned those lessons into a passion for advocating for others. Her journey and dedication are not only heartening but also motivational.

Read her story and discover how her efforts are helping to shape the landscape of kidney cancer research:

The increasing number of approved treatment combinations for metastatic renal cell carcinoma highlights the need for actionable biomarkers to guide treatment selection.

In this issue of Cancer Cell, Saliby et al. validate the distinct clinico-genomic profiles of expression-based molecular clusters identified in the IMmotion151 trial in the JAVELIN Renal 101 dataset.

Note: the first author is Renée Saliby, featured in our March community spotlight!

Calling All Researchers:

We Want You to Share Your Work

Punch your (sponsored!) ticket to #KCRS24 in Boston, and share the stage with leading kidney cancer researchers. The deadline to submit abstracts is quickly approaching!

Are you following KidneyCAN online? Tag @KidneyCAN

in your #kidneycancer posts!

Did you know?

According to the IKCC's 2022 Global Patient Survey, two-thirds of kidney cancer patients were not told what subtype of kidney cancer they had when they were diagnosed. Stay informed! Find information and help at our Patient Resource Center.

Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding and facilitating research collaborations. Much of our work is funded by grassroots donors from all over the United States. We can't do this without your support.

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Programs (CDMRP) or KCRP (Kidney Cancer Research Program). KidneyCAN's work is funded entirely through donations and contributions.